PMID- 24132183 OWN - NLM STAT- MEDLINE DCOM- 20140303 LR - 20161125 IS - 1521-0111 (Electronic) IS - 0026-895X (Linking) VI - 85 IP - 1 DP - 2014 Jan TI - Maternal exposure to dioxin imprints sexual immaturity of the pups through fixing the status of the reduced expression of hypothalamic gonadotropin-releasing hormone. PG - 74-82 LID - 10.1124/mol.113.088575 [doi] AB - Our previous studies have shown that treatment of pregnant rats with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; 1 mug/kg) at gestational day (GD) 15 reduces the pituitary synthesis of luteinizing hormone (LH) during the late fetal and early postnatal period, leading to the imprinting of defects in sexual behaviors at adulthood. However, it remains unclear how the attenuation of pituitary LH is linked to sexual immaturity. To address this issue, we performed a DNA microarray analysis to identify the gene(s) responsible for dioxin-induced sexual immaturity on the pituitary and hypothalamus of male pups, born of TCDD-treated dams, at the age of postnatal day (PND) 70. Among the reduced genes, we focused on gonadotropin-releasing hormone (GnRH) in the hypothalamus because of published evidence that it has a role in sexual behaviors. An attenuation by TCDD of GnRH expression emerged at PND4, and no subsequent return to the control level was seen. A change in neither DNA methylation nor histone acetylation accounted for the reduced expression of GnRH. Intracerebroventricular infusion of GnRH to the TCDD-exposed pups after reaching maturity restored the impairment of sexual behaviors. Supplying equine chorionic gonadotropin, an LH-mimicking hormone, to the TCDD-exposed fetuses at GD15 resulted in a recovery from the reduced expression of GnRH, as well as from the defects in sexual behavior. These results strongly suggest that maternal exposure to TCDD fixes the status of the lowered expression of GnRH in the offspring by reducing the LH-assisted steroidogenesis at the perinatal stage, and this mechanism imprints defects in sexual behaviors at adulthood. FAU - Takeda, Tomoki AU - Takeda T AD - Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan (T.T., M.F., Y.H., T.S., Y.I., H.Y.); and Faculty of Pharmaceutical Sciences, Nagasaki International University, Sasebo, Japan (M.Y., M.H.). FAU - Fujii, Misaki AU - Fujii M FAU - Hattori, Yukiko AU - Hattori Y FAU - Yamamoto, Midori AU - Yamamoto M FAU - Shimazoe, Takao AU - Shimazoe T FAU - Ishii, Yuji AU - Ishii Y FAU - Himeno, Masaru AU - Himeno M FAU - Yamada, Hideyuki AU - Yamada H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131016 PL - United States TA - Mol Pharmacol JT - Molecular pharmacology JID - 0035623 RN - 0 (Chorionic Gonadotropin) RN - 0 (Environmental Pollutants) RN - 0 (Polychlorinated Dibenzodioxins) RN - 33515-09-2 (Gonadotropin-Releasing Hormone) SB - IM MH - Animals MH - Animals, Newborn MH - Chorionic Gonadotropin/therapeutic use MH - DNA Methylation MH - Embryo, Mammalian MH - Environmental Pollutants/*toxicity MH - Female MH - Genomic Imprinting MH - Gonadotropin-Releasing Hormone/genetics/*metabolism/therapeutic use MH - Horses MH - Hypothalamus/*metabolism MH - Male MH - Maternal Exposure/*adverse effects MH - Maternal-Fetal Exchange MH - Pituitary Gland/metabolism MH - Polychlorinated Dibenzodioxins/*toxicity MH - Pregnancy MH - Prenatal Exposure Delayed Effects/drug therapy/etiology/*psychology MH - Rats MH - Rats, Wistar MH - *Sexual Behavior, Animal/drug effects MH - Testis/metabolism MH - Time Factors EDAT- 2013/10/18 06:00 MHDA- 2014/03/04 06:00 CRDT- 2013/10/18 06:00 PHST- 2013/10/18 06:00 [entrez] PHST- 2013/10/18 06:00 [pubmed] PHST- 2014/03/04 06:00 [medline] AID - mol.113.088575 [pii] AID - 10.1124/mol.113.088575 [doi] PST - ppublish SO - Mol Pharmacol. 2014 Jan;85(1):74-82. doi: 10.1124/mol.113.088575. Epub 2013 Oct 16.